Evidence map›Paper›PMID 35591548›Full record

ReviewMaterials (Basel, Switzerland)2022

Quo Vadis, Nanothermite? A Review of Recent Progress.

Mateusz Polis, Agnieszka Stolarczyk, Karolina Glosz, Tomasz Jarosz

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mateusz PolisŁukasiewicz Research Network-Institute of Industrial Organic Chemistry, Explosive Techniques Research Group, 42-693 Krupski Młyn, Poland.ORCID 0000-0002-4156-449X
Agnieszka StolarczykDepartment of Physical Chemistry and Technology of Polymers, Silesian University of Technology, 44-100 Gliwice, Poland.ORCID 0000-0001-9594-9072
Karolina GloszDepartment of Physical Chemistry and Technology of Polymers, Silesian University of Technology, 44-100 Gliwice, Poland.ORCID 0000-0001-9297-6972
Tomasz JaroszDepartment of Physical Chemistry and Technology of Polymers, Silesian University of Technology, 44-100 Gliwice, Poland.ORCID 0000-0001-8870-3760

Funding

Institute of Industrial Organic Chemistry 0/21/028/KSilesian University of Technology 04/040/BKM21/0173Silesian University of Technology 04/040/RGJ22/0198Silesian University of Technology 04/040/RGJ22/0201
6 · The paper itself

Abstract

One of the groups of pyrotechnic compositions is thermite compositions, so-called thermites, which consist of an oxidant, usually in the form of a metal oxide or salt, and a free metal, which is the fuel. A characteristic feature of termite combustion reactions, apart from their extremely high exothermicity, is that they proceed, for the most part, in liquid and solid phases. Nanothermites are compositions, which include at least one component whose particles size is on the order of nanometers. The properties of nanothermites, such as high linear burning velocities, high reaction heats, high sensitivity to stimuli, low ignition temperature, ability to create hybrid compositions with other high-energy materials allow for a wide range of applications. Among the applications of nanothermites, one should mention igniters, detonators, microdetonators, micromotors, detectors, elements of detonation chain or elements allowing self-destruction of systems (e.g., microchips). The aim of this work is to discuss the preparation methods, research methods, direction of the future development, eventual challenges or problems and to highlight the applications and emerging novel avenues of use of these compositions.

Indexed as

energetic materialshigh-energy materialsnanothermitethermite

Identifiers

PMID35591548
PMCPMC9105280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.